Autoimmune Polyglandular Syndrome Type 2 (APS-2)

What is APS-2?

APS-2 (Schmidt Syndrome) is the most common autoimmune polyglandular syndrome, characterized by Addison's disease (adrenal insufficiency) combined with either autoimmune thyroid disease and/or type 1 diabetes. It typically presents in adulthood.

Diagnostic Criteria (Must Have Addison's + At Least One Other):

  • Addison's Disease (100% - Required): Primary adrenal insufficiency
  • PLUS one or both of:
    • Autoimmune Thyroid Disease (70-80%): Hashimoto's thyroiditis or Graves' disease
    • Type 1 Diabetes (30-50%)

Other Associated Conditions:

  • Primary Hypogonadism
  • Celiac Disease (common)
  • Pernicious Anemia
  • Vitiligo (10-20%)
  • Myasthenia Gravis
  • Alopecia Areata

Key Differ ences from APS-1:

  • Age of Onset: Adulthood (20s-40s) vs. childhood (APS-1)
  • Genetics: Polygenic/HLA-associated vs. single gene (AIRE) in APS-1
  • More Common: 1-2 per 100,000 vs. very rare APS-1
  • NO Candidiasis or Hypoparathyroidism (unlike APS-1)
  • Female Predominance: 3:1 female:male ratio

Diagnosis & Management:

  • Screen for Other Autoimmune Diseases: Once one is diagnosed
  • Annual Surveillance: TSH, fasting glucose, celiac screening
  • Hormone Replacement:
    • Hydrocortisone (for Addison's)
    • Levothyroxine (if hypothyroid)
    • Insulin (if diabetic)
  • Emergency Precautions: Steroid emergency card, stress dosing education
  • Family Screening: Siblings have increased risk

Key Points:

  • APS-2 = Addison's disease + autoimmune thyroid disease and/or type 1 diabetes
  • Most common polyglandular syndrome
  • Adult onset (20s-40s)
  • Lifelong surveillance for additional autoimmune conditions
  • Requires multiple hormone replacements